Monoamine Signalling Pathways as a Target for Pathomechanism of Mental Disorders and Pharmacotherapy
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 114
Special Issue Editor
Interests: neurobiology; pharmacology; stress; psychiatric disorders
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The monoaminergic system comprises norepinephrine, dopamine, serotonin, and histamine neurotransmitter pathways and is known to regulate arousal, emotion, and memory. On the other hand, the functioning of these pathways is compromised by neuropsychiatric disorders, including depression, schizophrenia, or neurodegenerative diseases. The involvement of the monoamine neurotransmission system in the development of psychiatric disorders is elusive, and available pharmacotherapy counteracting monoaminergic system impairments is not effective enough. The purpose of the Special Issue is to collect original research articles and review papers focused on untangling the complexity of engagement of monoaminergic signal transduction in the pathology of brain function. We aim to bring together the most recent studies that use different experimental approaches in vivo or in vitro broadly related to the following:
- Signalling alterations in psychiatric disorders;
- Regulation of neurotransmission by monoamines/monoamine signalling effectors;
- Psychiatric disorder biomarkers;
- Novel therapies/therapeutic approaches for mental diseases.
Dr. Agnieszka Zelek-Molik
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- monoaminergic system
- psychiatric disorders
- neurotransmission regulation
- biomarkers
- novel therapies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
